Autophagy facilitates the Lapatinib resistance of HER2 positive breast cancer cells
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference37 articles.
1. Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer;Curigliano;J Clin Oncol,2009
2. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells;Pommier;Ann Surg Oncol,2010
3. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010
4. Lapatinib plus capecitabine for HER2-positive advanced breast cancer;Geyer;N Engl J Med,2006
5. Lapatinib for breast cancer: a review of the current literature;Macfarlane;Expert Opin Drug Saf,2011
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in the study of autophagy in breast cancer;Breast Cancer;2024-02-05
2. Identification of autophagy related genes predicting response of trastuzumab resistance in breast cancer patients;2023-10-05
3. Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy;Cells;2023-04-14
4. Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells;Chemical Biology & Drug Design;2023-02-15
5. The cross-talk of autophagy and apoptosis in breast carcinoma: implications for novel therapies?;Biochemical Journal;2022-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3